छोड़कर सामग्री पर जाएँ

Latest News

Jefferies cuts target, lowers EPS estimates of Cipla; flags delay in FDA approvals

Jefferies cuts target, lowers EPS estimates of Cipla; flags delay in FDA approvals

Cipla#39;s largest Indian facilities including Goa and Indore are under the regulatory scanner, which could impact new launches in the medium term. It estimates the value of India business at Rs 680 per share. Read More ​ Cipla#39;s largest Indian facilities… और पढ़ें »Jefferies cuts target, lowers EPS estimates of Cipla; flags delay in FDA approvals

Jefferies cuts target, lowers EPS outlook for Cipla; flags delay in FDA approvals

Jefferies cuts target, lowers EPS outlook for Cipla; flags delay in FDA approvals

Cipla#39;s largest Indian facilities including Goa and Indore are under the regulatory scanner, which could impact new launches in the medium term. It estimates the value of India business at Rs 680 per share. Read More ​ Cipla#39;s largest Indian facilities… और पढ़ें »Jefferies cuts target, lowers EPS outlook for Cipla; flags delay in FDA approvals

Zydus Lifesciences gets final USFDA approval for cancer drug; shares flat

Zydus Lifesciences gets final USFDA approval for cancer drug; shares flat

Lenalidomide Capsules works by slowing or stopping the growth of cancer cells. Read More ​ Lenalidomide Capsules works by slowing or stopping the growth of cancer cells. Lenalidomide Capsules works by slowing or stopping the growth of cancer cells.  Moneycontrol Latest News Read… और पढ़ें »Zydus Lifesciences gets final USFDA approval for cancer drug; shares flat

Zydus Lifesciences gets final USFDA approval for cancer drug; shares flat

Zydus Lifesciences gets final USFDA approval for cancer drug; shares flat

Lenalidomide Capsules works by slowing or stopping the growth of cancer cells. Read More ​ Lenalidomide Capsules works by slowing or stopping the growth of cancer cells. Lenalidomide Capsules works by slowing or stopping the growth of cancer cells.  Moneycontrol Latest News Read… और पढ़ें »Zydus Lifesciences gets final USFDA approval for cancer drug; shares flat

hi_INहिन्दी